Related Experiment Video
Updated: Aug 16, 2026

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer
Published on: March 17, 2016
Estrogen receptor beta in health and disease
Otabek Imamov1, Gil-Jin Shim, Margaret Warner
1Department of Biosciences and Medical Nutrition, Novum, Karolinska Institute, Karolinska University Hospital, Huddinge, SE-141 86 Sweden.
Abstract:
Estrogens, acting through its two receptors, ESR1 (hereafter designated ER alpha) and ESR2 (hereafter designated ER beta), have diverse physiological effects in the reproductive system, bone, cardiovascular system, hematopoiesis, and central and peripheral nervous systems. Mice with inactivated ER alpha, ER beta, or both show a number of interesting phenotypes, including incompletely differentiated epithelium in tissues under steroidal control (prostate, ovary, mammary, and salivary glands) and defective ovulation reminiscent of polycystic ovarian syndrome in humans (in ER beta-/- mice), and obesity, insulin resistance, and complete infertility (both in male and female ER alpha-/- mice). Estrogen agonists and antagonists are frequently prescribed drugs with indications that include postmenopausal syndrome (agonists) and breast cancer (antagonists). Because the two estrogen receptors (ERs) have different physiological functions and have ligand binding pockets that differ enough to be selective in their ligand binding, opportunities now exist for development of novel ER subtype-specific selective-ER modulators.
Insights
Estrogen receptors ER alpha and ER beta regulate many bodily functions. Understanding their distinct roles and developing targeted therapies could lead to new treatments for various conditions.
Area of Science:
- Endocrinology
- Molecular Biology
- Pharmacology
Background:
- Estrogens exert broad physiological effects via two receptors: ER alpha (ESR1) and ER beta (ESR2).
- These receptors influence reproductive, skeletal, cardiovascular, hematological, and neurological systems.
- Dysfunctional estrogen signaling is implicated in conditions like polycystic ovarian syndrome, obesity, and infertility.
Purpose of the Study:
- To investigate the distinct physiological roles of ER alpha and ER beta.
- To explore the therapeutic potential of targeting specific estrogen receptor subtypes.
Main Methods:
- Analysis of phenotypes in genetically modified mice lacking ER alpha, ER beta, or both.
- Review of current therapeutic applications of estrogen agonists and antagonists.
Main Results:
- Inactivation of ER alpha or ER beta in mice leads to specific developmental and physiological defects.
- ER beta deficiency is associated with defective ovulation, mimicking polycystic ovarian syndrome.
- ER alpha deficiency results in obesity, insulin resistance, and infertility in both sexes.
Conclusions:
- ER alpha and ER beta possess distinct functions crucial for normal physiology.
- Differences in receptor structure allow for selective ligand binding.
- Development of selective estrogen receptor modulators targeting specific ER subtypes offers therapeutic promise.
Related Concept Videos
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Intracellular Hormone Receptors
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Role of ER in the Secretory Pathway
Components of the secretory pathway
About a third of proteins synthesized in the cell are sorted via the secretory route. They shuffle between different compartments in membrane-bound vesicles until they reach their final destination. The main intracellular compartments involved...
Mitogens and the Cell Cycle
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
